{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T09:09:47Z","timestamp":1719824987643},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1984,4,1]],"date-time":"1984-04-01T00:00:00Z","timestamp":449625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":11567,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1984,4]]},"DOI":"10.1111\/1523-1747.ep12260607","type":"journal-article","created":{"date-parts":[[2004,7,22]],"date-time":"2004-07-22T11:42:19Z","timestamp":1090496539000},"page":"316-317","source":"Crossref","is-referenced-by-count":2,"title":["Mononuclear Leukocyte Cyclic Adenosine Monophosphate Responses in Psoriasis Are Normal"],"prefix":"10.1016","volume":"82","author":[{"given":"C B","family":"Archer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12260607_bb0010","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2133.1976.tb05137.x","article-title":"Immunological aspects of psoriasis. I. Immunoglobulins and anti IgG factors","volume":"94","author":"Guilhou","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2133.1976.tb07017.x","article-title":"Immunological aspects of psoriasis. II. Dissociated impairment of thymus-dependent lymphocytes","volume":"95","author":"Guilhou","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1346-8138.1976.tb01851.x","article-title":"The role of lymphoid and polymorphonuclear leukocytes in the pathogenesis of psoriasis","volume":"3","author":"Cormane","year":"1976","journal-title":"J Dermatol (Tokyo)"},{"key":"10.1111\/1523-1747.ep12260607_bb0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archderm.1980.01640280063020","article-title":"Lymphocyte cyclic nucleotide and prostaglandin content in psoriasis: a preliminary report","volume":"116","author":"Harpaz","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1001\/archderm.1972.01620080025008","article-title":"Decreased cyclic AMP in the epidermis of lesions of psoriasis","volume":"105","author":"Vorhees","year":"1972","journal-title":"Arch Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0035","first-page":"74","article-title":"Epidermal cyclic AMP is not decreased in psoriasis lesions","volume":"74","author":"Adachi","year":"1980","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/1523-1747.ep12514730","article-title":"Molecular mechanisms in proliferative skin disease","volume":"67","author":"Vorhees","year":"1976","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1159\/000250019","article-title":"Cyclic AMP and cyclic GMP production in normal and psoriatic epidermis","volume":"165","author":"Royer","year":"1982","journal-title":"Dermatologica"},{"key":"10.1111\/1523-1747.ep12260607_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/1523-1747.ep12507392","article-title":"Immunological aspects of psoriasis: V. T cell subsets and suppressor cell functions regulating immune responses in peripheral blood","volume":"78","author":"Clot","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0055","first-page":"221","article-title":"Razoxane therapy of psoriasis: comparison of T-cell sub-populations using monoclonal antibodies in treated and untreated patients","volume":"108","author":"Zachary","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0060","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/1523-1747.ep12541392","article-title":"Cyclic AMP accumulation in psoriatic skin: differential responses to histamine, AMP and epinephrine by the uninvolved and involved epidermis","volume":"70","author":"Iizuka","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/1523-1747.ep12541389","article-title":"Cyclic nucleotidephosphodiesterase in the involved and uninvolved skin in psoriasis","volume":"70","author":"Iizuka","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0070","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2133.1980.tb15847.x","article-title":"Cyclic AMP is decreased in mononuclear leukocytes from psoriatic patients","volume":"103","author":"Geerdink","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12260607_bb0075","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2133.1983.tb07679.x","article-title":"Impaired lymphocyte cyclic adenosine monophosphate responses in atopic eczema","volume":"109","author":"Archer","year":"1983","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15433500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15433500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T17:21:03Z","timestamp":1549387263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15433500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1984,4]]}},"alternative-id":["S0022202X15433500"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12260607","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1984,4]]}}}